AakashDesaiMD

PubMed

• BIO24-029: Predicting Disparities in Adverse Dispositions Following Major Surgery for Lung Cancer Using Machine Learning.
  Vijval Rajan, Mohammad Arfat Ganiyani, Yanjia Zhang, Zhenwei Zhang, Md Ashfaq Ahmed, Mukesh Roy, Venkataraghavan Ramamoorthy, Muni Rubens, Anshul Saxena, Atulya Aman K...> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 5
• ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer.
  Aakash Desai, Tadana A Vázquez, Keishla M Arce, Marcelo Corassa, Philip C Mack, Jhanelle E Gray, Bruna Pellini> ;Cancers. 2024 Feb 26
• 1 citations
  Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study.
  Amin H Nassar, Edward El-Am, Ryan Denu, Sarah Abou Alaiwi, Talal El Zarif, Walid Macaron, Noha Abdel-Wahab, Aakash Desai, Caleb Smith, Kaushal Parikh, Muhannad Abbasi,...> ;JACC. Cardiooncology. 2024 Feb 1
• Clinical Trials for Patients With Cancer.
  Fawzi Abu Rous, Aakash Desai, Eric K Singhi> ;JAMA Oncology. 2024 Mar 1
• Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies.
  Jongbloed, M., Bartolomeo, V., De Ruysscher, D., Hendriks, L., Khosla, A., Jatwani, K., Singh, R., Desai, A.> ;Current Oncology Reports. 2024 Jan 1
• 1 citations
  Analysis of Medicare Expenditure for Discarded Infused Cancer Therapeutics From 2017-2020.
  Jensen, C., Soefje, S., , Desai, A., Xiao, A., Smith, C., Pritchett, J., Durani, U., Go, R., Scheckel, C.> ;Mayo Clinic Proceedings. 2023 Dec 1
• Bispecific Antibodies in Lung Cancer: A State-of-the-Art Review.
  Atulya Aman Khosla, Karan Jatwani, Rohit Singh, Aswanth Reddy, Ishmael Jaiyesimi, Aakash Desai> ;Pharmaceuticals. 2023 Oct 14
• Toxicity From Sotorasib After Immune Checkpoint Inhibitors: A Note of Caution and Reflections of Future Advancements in the Field.
  Aakash Desai, Anastasios Dimou> ;Journal of Thoracic Oncology. 2023 Oct 1
• Superior clinical outcomes in patients with non-small cell lung cancer harboring multiplefusions treated with tyrosine kinase inhibitors.
  Qi Wei, Yuanyuan Zhang, Yongsheng Wang, Aakash Desai, Sihan Tan, Qin Huang, Xin Pu, Panwen Tian, Yalun Li> ;Translational Lung Cancer Research. 2023 Sep 28
• 4 citations
  Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.
  Aakash Desai, Caleb J Smith, Yash Ashara, Jacob J Orme, Saurabh Zanwar, Ashley Potter, Craig Hocum, J Nicole Moffett, Anna J Schwecke, Rami Manochakian, Yanyan Lou, Yu...> ;Clinical Lung Cancer. 2023 Dec 1
• The Association of Cervical Cancer Screening With Disability Type Among U.S. Women (Aged 25-64 Years).
  Amarachukwu F Orji, Gilbert Gimm, Aakash Desai, Tarang Parekh> ;American Journal of Preventive Medicine. 2024 Jan 1
• 7 citations
  Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report.
  Aakash Desai, Sagar Rakshit, Radhika Bansal, Yash Ashara, Ashley Potter, Rami Manochakian, Yanyan Lou, Yujie Zhao, Vinicius Ernani, Panos Savvides, Anna Schwecke, Nico...> ;Cancer Treatment and Research Communications. 2023 Jan 1
• Direct-to-Patient Clinical Trials: One Small Step or a Giant Leap?
  Aakash Desai, Vivek Subbiah> ;Clinical Cancer Research. 2023 Jul 5
• 2 citations
  Challenges in the implementation of ultrasensitive liquid biopsy approaches in precision oncology.
  Aakash Desai, Christine M Lovly> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• Dynamics and survival associations of T cell receptor clusters in patients with pleural mesothelioma treated with immunotherapy.
  Aakash P Desai, Farhad Kosari, Maria Disselhorst, Jun Yin, Alireza Agahi, Tobias Peikert, Julia Udell, Sarah H Johnson, James Smadbeck, Stephen Murphy, Giannoula Karag...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• Navigating approval pathways for immunotherapy in NSCLC: should criteria be revised?
  Aakash Desai, Caleb J Smith, Howard Jack West> ;Nature Reviews. Clinical Oncology. 2023 Jul 1
• 4 citations
  Professional Challenges for United States Hematology/Oncology Trainees during COVID-19.
  Rahul Banerjee, Samuel A Kareff, Natasha Dhawan, Lindsay R Hammons, Aakash Desai, Mazie Tsang, Ana I Velazquez, Amanda Nizam, Yan Leyfman> ;Cancer Investigation. 2023 Jul 1
• 4 citations
  Strategies to overcome resistance to ALK inhibitors in non-small cell lung cancer: a narrative review.
  Aakash Desai, Christine M Lovly> ;Translational Lung Cancer Research. 2023 Mar 31
• Hear Me Out: Mitigating Cisplatin-Induced Ototoxicity.
  Aakash Desai, Devika Das> ;JCO Oncology Practice. 2023 May 1
• 7 citations
  Immunotherapy-based combinations in metastatic NSCLC.
  Aakash Desai, Solange Peters> ;Cancer Treatment Reviews. 2023 May 1
• 1 citations
  Top advances of the year: Precision oncology.
  Aakash Desai, Neha K Reddy, Vivek Subbiah> ;Cancer. 2023 Jun 1
• 20 citations
  Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
  Vikas, P., Portuguese, A. J., Ziad Bakouny, Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih-Yuan Hsu, Saif I Alimohamed, Babar Bashir, Stephanie Berg, Me...> ;JAMA Oncology. 2023 Jan 1
• 10 citations
  Perioperative Immune Checkpoint Inhibition in Early-Stage Non-Small Cell Lung Cancer: A Review.
  Aakash P Desai, Jacob J Adashek, Joshua E Reuss, Howard Jack West, Aaron S Mansfield> ;JAMA Oncology. 2023 Jan 1
• 1 citations
  Antibody Drug Conjugates in Lung Cancer.
  Geoffrey Merle, Alex Friedlaender, Aakash Desai, Alfredo Addeo> ;Cancer Journal. 2022 Nov 16
• Failure to Launch: Why Some Generics Don't Take.
  Caleb J Scheckel, Aakash Desai, S Vincent Rajkumar> ;Mayo Clinic Proceedings. 2022 Nov 1
• Join now to see all